New drug formulation could treat Candida infections

April 28, 2020

With antimicrobial resistance (AMR) increasing around the world, new research led by the University of Bristol has shown a new drug formulation could possibly be used in antifungal treatments against Candida infections.

Candida albicans, a well-known yeast usually seen in the mouth, skin, gut and vagina, is reported to form biofilms and cause mild to life threatening infections. Fluconazole, an antifungal drug widely used to treat Candida infections is completely ineffective in treating Candida biofilms and new drugs are needed to treat them. However, unlike antibiotics, developing antifungal drugs is very challenging because yeast cells are structurally similar to human cells, as a result, there is a greater chance of unwanted side effects with new antifungal drugs. A better alternative would be to improve the efficiency of currently approved antifungal drugs such as fluconazole but with minimal side effects.

Recent studies have shown that microorganisms can communicate with each other using various chemical signals. Some microorganisms use these signals to control other competing microorganisms and these signals could potentially be used as antimicrobial drugs.

In the study, published in International Journal of Pharmaceutics, the researchers investigated whether using some of these microbial signals from bacteria could improve the activity of fluconazole against Candida biofilms.

The research team found that a specific chemical signal released from a major bacterial pathogen can be successfully used to significantly improve the activity of fluconazole against Candida biofilms by packaging them to small lipid molecules and delivering them together.

The pioneering research is one of only a few studies to demonstrate the possibility of using naturally existing microbial compounds against other pathogenic microorganisms.

Dr Nihal Bandara, Lecturer in Oral Microbiology from the Bristol Dental School and corresponding author, said: "It is well known that microorganisms live as "slime" communities, called "microbial biofilms", and are responsible for up to 80 per cent of all infections in humans. These microorganisms are extremely difficult to remove even with the most effective antimicrobial drugs. They can lead to a significant number of deaths and disabilities to patients and can be a healthcare and financial burden to economies around the world.

"It was really exciting to discover that we can use various signals released by microorganisms against others to control infections."

The research team would like to develop the technique used in the study and investigate the efficacy of new drug formulation using an animal model.

In the future, it is hoped researchers and pharmaceutical industries will explore the antimicrobial properties of microbial chemical signals so they can be developed into cost effective treatments.
-end-
This work was supported by IADR Innovation in Oral Care Award 2016 awarded to Dr Nihal Bandara by the International Association for Dental Research and GlaxoSmithKline.

The study was an international collaboration by a team from the University of Bristol, UK; University of Texas at Austin, USA; University of Queensland, Australia and University of Sharjah, UAE.

University of Bristol

Related Microorganisms Articles from Brightsurf:

A more resistant material against microorganisms is created to restore cultural heritage
The study was performed by a research team at the University Research Institute into Fine Chemistry and Nanochemistry at the University of Cordoba and Seville's Institute of Natural Resources and Agrobiology of the Spanish National Research Council

NYUAD study finds gene targets to combat microorganisms binding to underwater surfaces
A group of synthetic biologists at NYU Abu Dhabi (NYUAD) have identified new genetic targets that could lead to safe, biologically-based approaches to combat marine biofouling - the process of sea-based microorganisms, plants, or algae binding to underwater surfaces.

Less flocking behavior among microorganisms reduces the risk of being eaten
When algae and bacteria with different swimming gaits gather in large groups, their flocking behaviour diminishes, something that may reduce the risk of falling victim to aquatic predators.

Are vultures spreaders of microbes that put human health at risk?
A new analysis published in IBIS examines whether bacteria, viruses, and other microorganisms that are present in wild vultures cause disease in the birds, and whether vultures play a role in spreading or preventing infectious diseases to humans and other animal species.

Timing key in understanding plant microbiomes
Oregon State University researchers have made a key advance in understanding how timing impacts the way microorganisms colonize plants, a step that could provide farmers an important tool to boost agricultural production.

Advances in the production of minor ginsenosides using microorganisms and their enzymes
Advances in the Production of Minor Ginsenosides Using Microorganisms and Their Enzymes - BIO Integration https://bio-integration.org/wp-content/uploads/2020/05/bioi20200007.pdf Announcing a new article publication for BIO Integration journal.

Study shows how microorganisms survive in harsh environments
In northern Chile's Atacama Desert, one of the driest places on Earth, microorganisms are able to eke out an existence by extracting water from the rocks they colonize.

Microorganisms in parched regions extract needed water from colonized rocks
Cyanobacteria living in rocks in Chile's Atacama Desert extract water from the minerals they colonize and, in doing so, change the phase of the material from gypsum to anhydrite.

Verticillium wilt fungus killing millions of trees is actually an army of microorganisms
A research project studied the microbiome of olive tree roots and concluded that Verticillium wilt is fueled by a community of microorganisms that team up to attack plants, thus reassessing the way this problem is dealt with

New drug formulation could treat Candida infections
With antimicrobial resistance (AMR) increasing around the world, new research led by the University of Bristol has shown a new drug formulation could possibly be used in antifungal treatments against Candida infections.

Read More: Microorganisms News and Microorganisms Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.